Clinical factors influencing periocular surgical defects after Mohs micrographic surgery

被引:29
作者
Carter, KD
Nerad, JA
Whitaker, DC
机构
[1] Univ Iowa Hosp & Clin, Coll Med, Dept Ophthalmol, Oculoplast Orbital & Oncol Serv, Iowa City, IA 52242 USA
[2] Univ Iowa Hosp & Clin, Coll Med, Dept Dermatol, Iowa City, IA 52242 USA
关键词
D O I
10.1097/00002341-199903000-00004
中图分类号
R77 [眼科学];
学科分类号
100212 [眼科学];
摘要
Purpose: To determine if the surgical defect after excision of periocular skin cancers can be predicted preoperatively. Methods: Review of medical records of patients who underwent excision of periocular skin cancers between 1990 and 1995. Results: Two hundred sixty-four patients (157 men, 107 women) with a total of 281 malignant turners were treated. Basal cell carcinoma accounted for 92.2% of the tumors, whereas squamous cell carcinoma constituted 6.4% of lesions. The lower eyelid and medial canthus were the most frequent sites of involvement. Data analysis was conducted on tumor size, cell type, location, and the Mohs stages and sections that were required for cure. Morpheaform basal cell carcinomas required the most Mohs stages and sections and resulted in the largest excisional defects when compared with clinical tumor dimensions. The lateral canthus had the fewest tumors, but lesions in this area resulted in the largest excisional defects (mean, 9.5 cm(2)) when compared with lesions of the medial eyelid (p = 0.35). The average size of the defect after Mohs excision of basal cell carcinoma was 4.2 to 4.6 times the original clinical tumor size. For morpheaform basal cell carcinoma, however, the average excisional defect was 6.1 times larger. Conversely, the average defect after excision of squamous cell carcinoma was only 2.6 times as large as the original clinical tumor size. Conclusions: These data are useful in predicting the size of a defect after Mohs excision of periocular skin cancer, based on the original clinical tumor size.
引用
收藏
页码:83 / 91
页数:9
相关论文
共 43 条
[1]
ANDERSON RL, 1978, OPHTHALMOLOGY, V85, P1150
[2]
Aurora A.L., 1970, SURV OPHTHALMOL, V15, P94
[3]
REAPPRAISAL OF BASAL CELL CARCINOMA OF EYELIDS [J].
AURORA, AL ;
BLODI, FC .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1970, 70 (03) :329-&
[4]
BOREL DM, 1973, ARCH PATHOL, V95, P293
[5]
FROZEN SECTION CONTROL IN THE SURGERY OF BASAL-CELL CARCINOMA OF THE EYELID [J].
CHALFIN, J ;
PUTTERMAN, AM .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1979, 87 (06) :802-809
[6]
FACTORS PREDICTIVE OF RECURRENCE OF BASAL-CELL CARCINOMA [J].
DIXON, AY ;
LEE, SH ;
MCGREGOR, DH .
AMERICAN JOURNAL OF DERMATOPATHOLOGY, 1989, 11 (03) :222-232
[7]
FACTORS IN THE SUCCESSFUL SURGICAL-MANAGEMENT OF BASAL-CELL CARCINOMA OF THE EYELIDS [J].
DOXANAS, MT ;
GREEN, WR ;
ILIFF, CE .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1981, 91 (06) :726-736
[8]
SQUAMOUS-CELL CARCINOMA OF THE EYELIDS [J].
DOXANAS, MT ;
ILIFF, WJ ;
ILIFF, NT ;
GREEN, WR .
OPHTHALMOLOGY, 1987, 94 (05) :538-541
[9]
METASTASES FROM SQUAMOUS CELL CARCINOMAS OF SKIN [J].
EPSTEIN, E ;
EPSTEIN, NN ;
BRAGG, K ;
LINDEN, G .
ARCHIVES OF DERMATOLOGY, 1968, 97 (03) :245-+
[10]
FARMER ER, 1980, CANCER-AM CANCER SOC, V46, P748, DOI 10.1002/1097-0142(19800815)46:4<748::AID-CNCR2820460419>3.0.CO